Navigation Links
Prodigy Re-Launches Syringe-Filling System for Blind and Low-Vision Diabetics
Date:3/16/2010

The Prodigy® Count-a-dose is available April 1

Charlotte, N.C. (Vocus) March 16, 2010 -- Prodigy Diabetes Care, LLC, is launching its new Prodigy Count-a-dose™ April 1, a precise and safe syringe-filling device for the blind and visually impaired.

The Prodigy Count-a-dose™ offers diabetics a device which can easily measure and mix two insulins at one time. The device had been pulled from the market a year ago by another company, prompting an outcry from blind and low-vision diabetics. Prodigy® is coming to their rescue as of April 1.

The initial version uses touch and sound to allow diabetics to measure out dosages. Prodigy® plans to release a fully audible version in the future, which mirrors the company’s commitment to providing audible medical devices.

“We’ve perfected the device to make it simple for the blind or low-vision patient to easily and, above all, safely fill their own insulin syringes,” said Rick Admani Abulhaj, chief operating officer of Prodigy Diabetes Care. “Statistics say nearly 23 percent of diabetics suffer from blindness or low vision, so we’re driven to make products that will help make their lives easier. The Count-a-dose™ is another step toward independence.”

Prodigy® was the first to offer fully audible blood glucose meters for blind and low vision patients. It purchased the rights to the Count-a-dose™ last year with the goal of reintroducing the product for its core market. Count-a-dose™ is available April 1 by calling 1-866-908-9201.

ABOUT PRODIGY® GLUCOSE MONITORING SYSTEM
Prodigy® Meters are distributed by a privately owned company headquartered in Charlotte, NC, that develops, manufactures and markets technology-based diabetes products, with a focus on audible blood-glucose meters. The Prodigy® product line of
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Prodigy AutoCode Now Available in 116 Harris Teeter Pharmacies
2. Prodigy Again Teams Up with National Federation of the Blind at N.C. Convention
3. Prodigy Diabetes Care LLC Expands Global Reach to European Diabetes Patients
4. MedQuist Re-launches New, Improved Web Site
5. ASGE Re-Launches Colon Cancer Awareness Web Site www.Screen4coloncancer.Org for National Colorectal Cancer Awareness Month
6. LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
7. Gold Standard Re-launches ToxED Clinical Toxicology Poisoning and Drug Overdose Reference
8. MPR Re-Launches its Up-to-Date Drug Reference Website
9. The Midwest Center for Stress and Anxiety Re-launches Website for Stress, Anxiety, and Depression
10. HealthyPlace.com, the Largest Consumer Mental Health Site, Re-Launches With Important New Features for the More Than 30 Million People Who Suffer from Anxiety, Depression and Bipolar Disorder
11. Crown Consumer Brands Re-Launches DentaBurst(TM) Freshening Teeth Cleaners
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Prodigy Re-Launches Syringe-Filling System for Blind and Low-Vision Diabetics
(Date:4/22/2014)... percent of all lung cancers are small cell ... develop resistance to chemotherapy. However, researchers at Virginia ... insights into the mechanisms leading to this resistance ... Chemotherapies work primarily by mediating B-cell lymphoma 2 ... cell death. Depending on their function, this family ...
(Date:4/22/2014)... 2014Hemoglobin A1c is the standard measurement for assessing glycemic ... of A1c are typically measured every few months in ... model that accurately estimates A1c using self-monitored blood glucose ... Therapeutics ( DTT ), a peer-reviewed journal from ... free on the DTT website at ...
(Date:4/22/2014)... PHILADELPHIA (April 22, 2014) That person we all seem ... take action? Turns out he or she isn,t unable to ... A study of nearly ... about why neurotic people may avoid making decisions and moving ... if action is positive, favorable, good, they just don,t like ...
(Date:4/22/2014)... -- In parallel with modern man ( Homo sapiens ), ... we lived side by side, such as Neanderthals and the ... sapiens survived. What was it in our genetic makeup ... little is known about our unique genetic makeup as distinguished ... fact that we are the only species among them ,to ...
(Date:4/22/2014)... Disease (IBD), a group of chronic inflammatory disorders of ... affects over 1.4 million people in the U.S., and ... there is no cure. , Now, Cincinnati Cancer ... Susan Waltz, PhD, and scientists in her lab have ... genetic study to document the important function for the ...
Breaking Medicine News(10 mins):Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Neurotics don't just avoid action: They dislike it 2Health News:What gave us the advantage over extinct types of humans? 2Health News:Two genes linked to inflammatory bowel disease 2
... and predicting the tumours that will metastasize in lymph nodes ... 3rd International Conference on innovative approaches in Head and Neck ... Radboud University Nijmegen Medical Centre, the Netherlands, reported results of ... The study was jointly led by scientists from Nijmegen and ...
... Michigan State University has secured a $7.9 million ... Mozambique through increasing the African nation,s agricultural productivity, ... four-year grant, funded by the U.S. Agency for ... University of Florida. The initiative employs trilateral cooperation, ...
... of the factors reported by those who say they are unhappy ... its kind, published in the launch issue of the new online ... challenge the perception that these patients can no longer enjoy quality ... the authors. The research team quizzed 168 members of the ...
... four new grants to help improve awareness, prevention and ... in China and India. The grants total nearly $1 ... hepatitis-related health disparities in Asia to $8 million USD ... announced at the Asian Pacific Association for the Study ...
... 24 (HealthDay News) -- An analysis of proteins in spinal ... with chronic fatigue syndrome, a new study reports. It ... involve the central nervous system and that protein abnormalities in ... conditions, said the research team, which was led by Dr. ...
... suffer from delirium each year, however the condition goes ... if diagnosed, there is no effective way to treat ... professionals. Researchers, clinicians, and administrators from across ... - 7 for "Advancing Delirium Care through Research," the ...
Cached Medicine News:Health News:Gene expression to distinguish metastasizing from non-metastasizing head and neck cancers 2Health News:$7.9 million grant to improve food security, nutrition in Mozambique 2Health News:Most 'locked-in syndrome' patients say they are happy 2Health News:Bristol-Myers Squibb Foundation awards nearly $1M to HBV, HCV awareness, prevention and care 2Health News:Bristol-Myers Squibb Foundation awards nearly $1M to HBV, HCV awareness, prevention and care 3Health News:Spinal Fluid May Hold Clues to Lyme Disease, Chronic Fatigue Syndrome 2Health News:Advancing delirium care through research 2
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th edition ... Convention Center from January 21-24. (Logo: ... from top pharmaceutical, fine chemical and specialty chemical companies will ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Inquire...
Rapid Urease test for the presumptive identification of H. pylori in gastric mucosal biopsies...
... The QuickVue H.pylori gII test is a ... qualitative detection of IgG antibodies specific to ... whole blood. It utilizes a convenient, non-invasive, ... aid physicians in the diagnosis of H.pylori ...
... a visually read, qualitative immunochromatographic method for ... a bacterium that grows in the stomach ... and some gastric cancers. FlexSure HP, available ... serum samples, provides the physician with the ...
Medicine Products: